Skip to main content

Clinical Neuroimmunology

The group of Clinical Neuroimmunology - Centre d'Esclerosi Múltiple de Catalunya (Cemcat) at the Vall d'Hebron Institut de Recerca (VHIR) is a multidisciplinary group dedicated to clinical assistance, physical and cognitive rehabilitation, and clinical and basic research on multiple sclerosis (MS). Cemcat is a national but also an international reference center in the clinical assistance of MS patients. The research performed in the group is divided and further combined in clinical and basic research. In addition, basic research has a marked translational character since the ultimate goal of the group is to improve the quality of life of patients suffering from MS, through in-depth knowledge of the pathogenic mechanisms of the disease and the development of new and more effective therapeutic approaches. 

Publications

Genetic influences on disease course and severity, 30 years after a clinically isolated syndrome.

PMID: 37841069
Journal: Brain communications
Year: 2023
Reference: Brain Commun. 2023 Oct 4;5(5):fcad255. doi: 10.1093/braincomms/fcad255. eCollection 2023.
Impact factor:
Publication type: Paper in international publication
Authors: Barkhof, Frederik; Brownlee, Wallace; Castano, Carlos; Chard, Declan; Chung, Karen; Ciccarelli, Olga; Dominguez, Carlos; Gandini Wheeler-Kingshott, Claudia A M; Gramegna, Laura Ludovica; Haider, Lukas et al.
DOI: 10.1093/braincomms/fcad255

Teriflunomide and Epstein-Barr virus in a Spanish multiple sclerosis cohort: in vivo antiviral activity and clinical response.

PMID: 37841253
Journal: Frontiers in Immunology
Year: 2023
Reference: Front Immunol. 2023 Sep 29;14:1248182. doi: 10.3389/fimmu.2023.1248182. eCollection 2023.
Impact factor:
Publication type: Paper in international publication
Authors: Aladro, Yolanda; Alia, Eva Maria Guerra; Alvarez-Lafuente, Roberto; Arroyo, Rafael; Baurain, Jean-Francois; Braicu, Elena Ioana; Casanova-Peno, Ignacio; Colombo, Nicoletta; Comabella, Manuel; Costa-Frossard, Lucienne et al.
DOI: 10.3389/fimmu.2023.1248182

Impact of obesity and lung function on the efficacy of biological treatment in patients with asthma.

PMID: 37850411
Journal: JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY
Year: 2023
Reference: J Investig Allergol Clin Immunol. 2023 Oct 18:0. doi: 10.18176/jiaci.0941.
Impact factor:
Publication type: Paper in international publication
Authors: Aladro, Yolanda; Alvarez-Lafuente, Roberto; Arroyo, Rafael; Casanova-Peno, Ignacio; Comabella, Manuel; Costa-Frossard, Lucienne; Cruz, M J; Dominguez-Mozo, Maria Inmaculada; Espejo, D; Garcia-Dominguez, Jose Manuel et al.
DOI: 10.18176/jiaci.0941

Cetuximab every 2 weeks versus standard weekly dosing administration schedule.

PMID: 37850363
Journal: Future Oncology
Year: 2023
Reference: Future Oncol. 2023 Oct 18. doi: 10.2217/fon-2023-0282.
Impact factor:
Publication type: Paper in international publication
Authors: Barkhof, Frederik; Bokemeyer, Carsten; Brownlee, Wallace; Chard, Declan; Chung, Karen; Ciardiello, Fortunato; Ciccarelli, Olga; Dubreuil, Olivier; Esser, Regina; Gandini Wheeler-Kingshott, Claudia A M et al.
DOI: 10.2217/fon-2023-0282

Body mass index as a predictor of MS activity and progression among participants in BENEFIT.

PMID: 34994579
Journal: Multiple Sclerosis Journal
Year: 2022
Reference: Mult Scler. 2022 Jul;28(8):1277-1285. doi: 10.1177/13524585211061861. Epub 2022 Jan 7.
Impact factor:
Publication type: Paper in international publication
Authors: Ascherio, Alberto; Barkhof, Frederik; Cortese, Marianna; Edan, Gilles; Freedman, Mark S; Hartung, Hans-Peter; Kappos, Ludwig; Manuel Escobar, Juan; Montalban, Xavier; Munger, Kassandra L et al.
DOI: 10.1177/13524585211061861

Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health Solutions.

PMID: 34994577
Journal: Multiple Sclerosis Journal
Year: 2022
Reference: Mult Scler. 2022 Jun;28(7):1131-1137. doi: 10.1177/13524585211061343. Epub 2022 Jan 7.
Impact factor:
Publication type: Paper in international publication
Authors: Bermel, Robert A; Cohen, Jeffrey A; Grossman, Cynthia I; Hersh, Carrie M; Hyland, Megan; Montalban, Xavier; Mowry, Ellen M; Naismith, Robert; Naylor, Maria L; Nicholas, Jacqueline et al.
DOI: 10.1177/13524585211061343

Herpes simplex encephalitis in the context of immune checkpoint inhibitors: a complex interplay.

PMID: 34988947
Journal: ACTA NEUROLOGICA BELGICA
Year: 2022
Reference: Acta Neurol Belg. 2022 Jun;122(3):823-825. doi: 10.1007/s13760-021-01864-2. Epub 2022 Jan 6.
Impact factor:
Publication type: Letter or abstract
Authors: Auger, Cristina; Callejo, Ana; Cobo-Calvo, Alvaro; Lallana, Sofia; Rio, Jordi; Sanchez-Tejerina, Daniel et al.
DOI: 10.1007/s13760-021-01864-2

Treatment response scoring systems to assess long-term prognosis in self-injectable DMTs relapsing-remitting multiple sclerosis patients.

PMID: 34596743
Journal: JOURNAL OF NEUROLOGY
Year: 2022
Reference: J Neurol. 2022 Jan;269(1):452-459. doi: 10.1007/s00415-021-10823-z. Epub 2021 Oct 1.
Impact factor:
Publication type: Paper in international publication
Authors: Arrambide, Georgina; Auger, Cristina; Castillo, Joaquim; Cobo, Alvaro; Comabella, Manuel; Galan, Ingrid; Gasperini, Claudio; Midaglia, Luciana; Montalban, Xavier; Nos, Carlos et al.
DOI: 10.1007/s00415-021-10823-z

Machine and deep learning in MS research are just powerful statistics - Yes.

PMID: 33625280
Journal: Multiple Sclerosis Journal
Year: 2021
Reference: Mult Scler. 2021 Apr;27(5):661-662. doi: 10.1177/1352458520981309. Epub 2021 Feb 24.
Impact factor:
Publication type: Paper in international publication
Authors: Tur, Carmen et al.
DOI: 10.1177/1352458520981309

Development and evaluation of a manual segmentation protocol for deep grey matter in multiple sclerosis: Towards accelerated semi-automated references.

PMID: 33882422
Journal: NeuroImage-Clinical
Year: 2021
Reference: Neuroimage Clin. 2021;30:102659. doi: 10.1016/j.nicl.2021.102659. Epub 2021 Apr 6.
Impact factor: 4.881
Publication type: Paper in international publication
Authors: Simoes, Jorge, Ruggieri, Serena, Schregel, Katharina, Ropele, Stefan, Rocca, Maria A, Gasperini, Claudio, Gallo, Antonio, Schoonheim, Menno M, Amann, Michael, Yiannakas, Marios et al.
DOI: 10.1016/j.nicl.2021.102659

Systematic CT perfusion acquisition in acute stroke increases vascular occlusion detection and thrombectomy rates.

PMID: 34857668
Journal: Journal of NeuroInterventional Surgery
Year: 2021
Reference: J Neurointerv Surg. 2021 Dec 2. pii: neurintsurg-2021-018241. doi: 10.1136/neurintsurg-2021-018241.
Impact factor: 5.836
Publication type: Paper in international publication
Authors: Olive-Gadea, Marta, Requena, Manuel, Diaz, Facundo, Boned, Sandra, Garcia-Tornel, Alvaro, Muchada, Marian, Deck, Matias, Lozano, Prudencio, Rodriguez-Villatoro, Noelia, Juega, Jesus et al.
DOI: 10.1136/neurintsurg-2021-018241

Assessment of automatic decision-support systems for detecting active T2 lesions in multiple sclerosis patients.

PMID: 34859704
Journal: Multiple Sclerosis Journal
Year: 2021
Reference: Mult Scler. 2021 Dec 3:13524585211061339. doi: 10.1177/13524585211061339.
Impact factor: 6.312
Publication type: Paper in international publication
Authors: Rovira, Alex, Corral, Juan Francisco, Auger, Cristina, Valverde, Sergi, Vidal-Jordana, Angela, Ng Wong, Yiken Karelys, Tintore, Mar, Pareto, Deborah, Aymerich, Francesc Xavier, Montalban, Xavier et al.
DOI: 10.1177/13524585211061339

[Correction] Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk.

PMID: 31978348
Journal: CELL
Year: 2020
Reference: Cell. 2020 Jan 23;180(2):403. doi: 10.1016/j.cell.2020.01.002.
Impact factor:
Publication type: Letter or abstract
Authors: Agliardi, Cristina; Alfredsson, Lars; Andlauer, Till F M; Ban, Maria; Baranzini, Sergio E; Barcellos, Lisa F; Barizzone, Nadia; Bayas, Antonios; Beecham, Ashley H; Bergh, Florian Then et al.
DOI: 10.1016/j.cell.2020.01.002

Consensus document on the multidisciplinary management of neurogenic lower urinary tract dysfunction in patients with multiple sclerosis.

PMID: 31943361
Journal: NEUROUROLOGY AND URODYNAMICS
Year: 2020
Reference: Neurourol Urodyn. 2020 Feb;39(2):762-770. doi: 10.1002/nau.24276. Epub 2020 Jan 15.
Impact factor:
Publication type: Paper in international publication
Authors: Adot, Jose Maria; Allue, Marta; Arlandis, Salvador; Blasco, Pedro; Casanova, Bonaventura; Lopez-Fando, Luis; Madurga, Blanca; Matias-Guiu, Jorge; Medina-Polo, Jose; Meza-Murillo, Edwin-Roger et al.
DOI: 10.1002/nau.24276

The Rare IL22RA2 Signal Peptide Coding Variant rs28385692 Decreases Secretion of IL-22BP Isoform-1, -2 and -3 and Is Associated with Risk for Multiple Sclerosis.

PMID: 31936765
Journal: Cells
Year: 2020
Reference: Cells. 2020 Jan 10;9(1). pii: cells9010175. doi: 10.3390/cells9010175.
Impact factor:
Publication type: Paper in international publication
Authors: Aktas, Orhan; Alloza, Iraide; Altmann, Vivian; Antiguedad, Alfredo; Astobiza, Ianire; Buttmann, Mathias; Castillo-Trivino, Tamara; Chan, Andrew; Comabella, Manuel; Espino-Paisan, Laura et al.
DOI: 10.3390/cells9010175

Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies.

PMID: 31734402
Journal: AUTOIMMUNITY REVIEWS
Year: 2020
Reference: Autoimmun Rev. 2020 Jan;19(1):102429. doi: 10.1016/j.autrev.2019.102429. Epub 2019 Nov 15.
Impact factor:
Publication type: Review in international publication
Authors: Adan, Alfredo; Borruel, Natalia; Canete, Juan D; Dauden, Esteban; Garcia-Vidal, Carolina; Gonzalez-Gay, Miguel Angel; Juanatey, Carlos Gonzalez; Martin, Antonio Olveira; Martin, Esther Holgado; Montalban, Xavier et al.
DOI: 10.1016/j.autrev.2019.102429

Simultaneous CMV and Listeria infection following alemtuzumab treatment for multiple sclerosis.

PMID: 30587519
Journal: NEUROLOGY
Year: 2019
Reference: Neurology. 2019 Feb 5;92(6):296-298. doi: 10.1212/WNL.0000000000006801. Epub 2018 Dec 26.
Impact factor: 8.689
Publication type: Paper in international publication
Authors: Pappolla, Agustin, Midaglia, Luciana, Boix Rodriguez, Claudia P, Puig, Adaia Albasanz, Lung, Maiylyi, Camps, Isabel Ruiz, Castillo, Joaquin, Mulero, Patricia, Arrambide, Georgina, Rodriguez-Acevedo, Breogan et al.
DOI: 10.1212/WNL.0000000000006801

[Progressive multifocal leukoencephalopathy and non-specific immune dysfunction].

PMID: 30687923
Journal: REVISTA DE NEUROLOGIA
Year: 2019
Reference: Rev Neurol. 2019 Feb 1;68(3):132-133.
Impact factor: 0.485
Publication type: Letter whit IF
Authors: Llaurado-Gayete, A, Campos-Fernandez, D, Olive-Gadea, M, Ballve-Martin, A, Rio, J, Rovira, A, Santamarina, E et al.
DOI: 10.33588/rn.6803.2018377

Frequency and relevance of IgM, and IgA antibodies against MOG in MOG-IgG-associated disease.

PMID: 30623863
Journal: Multiple Sclerosis and Related Disorders
Year: 2019
Reference: Mult Scler Relat Disord. 2019 Feb;28:230-234. doi: 10.1016/j.msard.2019.01.007. Epub 2019 Jan 3.
Impact factor: 2.725
Publication type: Paper in international publication
Authors: Sepulveda, Maria, Armangue, Thais, Sabater, Lidia, Martinez-Hernandez, Eugenia, Arrambide, Georgina, Blanco, Yolanda, Llufriu, Sara, Martinez-Lapiscina, Elena H, Mulero, Patricia, Sola-Valls, Nuria et al.
DOI: 10.1016/j.msard.2019.01.007

Patient and caregiver involvement in formulation of guideline questions: Findings from the EAN Guideline on Palliative Care of People with Severe Multiple Sclerosis.

PMID: 30035845
Journal: EUROPEAN JOURNAL OF NEUROLOGY
Year: 2019
Reference: Eur J Neurol. 2019 Jan;26(1):41-50. doi: 10.1111/ene.13760. Epub 2018 Sep 9.
Impact factor: 4.387
Publication type: Paper in international publication
Authors: Kopke, Sascha, Giordano, Andrea, Veronese, Simone, Rahn, Anne Christin, Kleiter, Ingo, Basedow-Rajwich, Birgit, Fornari, Arianna, Battaglia, Mario Alberto, Drulovic, Jelena, Kooij, Liesbeth et al.
DOI: 10.1111/ene.13760

NLRP3 polymorphisms and response to interferon-beta in multiple sclerosis patients.

PMID: 29117789
Journal: Multiple Sclerosis Journal
Year: 2018
Reference: Mult Scler. 2018 Oct;24(11):1507-1510. doi: 10.1177/1352458517739137. Epub 2017 Nov 9.
Impact factor: 5.28
Publication type: Paper in international publication
Authors: Malhotra, Sunny, Sorosina, Melissa, Rio, Jordi, Peroni, Silvia, Midaglia, Luciana, Villar, Luisa M, Alvarez-Cermeno, Jose C, Schroeder, Ina, Esposito, Federica, Clarelli, Ferdinando et al.
DOI: 10.1177/1352458517739137

Brain atrophy 15 years after CIS: Baseline and follow-up clinico-radiological correlations.

PMID: 28445084
Journal: Multiple Sclerosis Journal
Year: 2018
Reference: Mult Scler. 2018 May;24(6):721-727. doi: 10.1177/1352458517707070. Epub 2017 Apr 26.
Impact factor: 5.28
Publication type: Paper in international publication
Authors: Huerga, Elena, Mitjana, Raquel, Auger, Cristina, Tintore, Mar, Rovira, Alex, Montalban, Xavier, Otero-Romero, Susana, Arrambide, Georgina, Pareto, Deborah, Vidal-Jordana, Angela et al.
DOI: 10.1177/1352458517707070

Ocrelizumab: a new milestone in multiple sclerosis therapy.

PMID: 29774057
Journal: Therapeutic Advances in Neurological Disorders
Year: 2018
Reference: Ther Adv Neurol Disord. 2018 May 10;11:1756286418773025. doi: 10.1177/1756286418773025. eCollection 2018.
Impact factor: 4.75
Publication type: Review in international publication
Authors: Mulero, Patricia, Midaglia, Luciana, Montalban, Xavier et al.
DOI: 10.1177/1756286418773025

Clinical commentary on "Two cases of anaphylactic shock by methylprednisolone in neuromyelitis optica".

PMID: 29671675
Journal: Multiple Sclerosis Journal
Year: 2018
Reference: Mult Scler. 2018 Oct;24(11):1516-1517. doi: 10.1177/1352458518771259. Epub 2018 Apr 19.
Impact factor: 5.28
Publication type: Editorail in international publication
Authors: Rio, Jordi, Rodriguez-Acevedo, Breogan et al.
DOI: 10.1177/1352458518771259

Should we systematically test patients with clinically isolated syndrome for auto-antibodies?

PMID: 25778697
Journal: Multiple Sclerosis Journal
Year: 2015
Reference: Mult Scler. 2015 Dec;21(14):1802-10. doi: 10.1177/1352458515575338. Epub 2015 Mar 16.
Impact factor: 4.822
Publication type: Paper in international publication
Authors: Simon, Eva, Castillo, Joaquin, Palavra, Filipe, Mitjana, Raquel, Auger, Cristina, Rovira, Alex, Montalban, Xavier, Vidal-Jordana, Angela, Galan, Ingrid, Nos, Carlos et al.
DOI: 10.1177/1352458515575338

Predictive value of early brain atrophy on response in patients treated with interferon beta.

PMID: 26185778
Journal: Neurology: Neuroimmunology & Neuroinflammation
Year: 2015
Reference: Neurol Neuroimmunol Neuroinflamm. 2015 Jul 2;2(4):e132. doi: 10.1212/NXI.0000000000000132. eCollection 2015 Aug.
Impact factor:
Publication type: Letter or abstract
Authors: Perez-Miralles, Francisco Carlos, Sastre-Garriga, Jaume, Vidal-Jordana, Angela, Rio, Jordi, Auger, Cristina, Pareto, Deborah, Tintore, Mar, Rovira, Alex, Montalban, Xavier et al.
DOI: 10.1212/NXI.0000000000000132

[Compliance of the guidelines of the Spanish Neurology Society in the treatment of patients with multiple sclerosis].

PMID: 26204085
Journal: REVISTA DE NEUROLOGIA
Year: 2015
Reference: Rev Neurol. 2015 Aug 16;61(4):145-52.
Impact factor: 0.83
Publication type: Clinical guide
Authors: Rio, Jordi, Gobartt, Ana L, Ramio-Torrenta, Ll, Munteis-Olivas, E, Perez-Trullen, J M, Bujanda-Alegria, M, Solar-Sanchez, D M, Menendez-Gonzalez, M, Marey-Lopez, J, Llaneza-Gonzalez, M A et al.
DOI:

Pharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN-beta.

PMID: 26445728
Journal: Neurology: Neuroimmunology & Neuroinflammation
Year: 2015
Reference: Neurol Neuroimmunol Neuroinflamm. 2015 Sep 24;2(5):e154. eCollection 2015 Oct.
Impact factor:
Publication type: Letter or abstract
Authors: Bustamante, Marta F, Morcillo-Suarez, Carlos, Malhotra, Sunny, Rio, Jordi, Leyva, Laura, Fernandez, Oscar, Zettl, Uwe K, Killestein, Joep, Brassat, David, Garcia-Merino, Juan Antonio et al.
DOI: 10.1212/NXI.0000000000000154

Blog

News

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

Dr. Carmen Espejo and Dr. Georgina Arrambide, researchers at Cemcat and Vall d'Hebron Research Institute, are the first authors of the article.

The research findings propose to modify the McDonald 2017 criteria, only in those in whom diagnosis using the current criteria is not possible.

Rates

Simoa HD1 equipment

We are seeking healthy volunteers for a study to find biomarkers of multiple sclerosis

We are looking for 100 healthy volunteers aged 18 or over to participate in a project where the usefulness of biomarkers in serum will be evaluated to predict the prognosis of the disease and the response to treatments.

More information